Keith Katkin - Apr 1, 2022 Form 3 Insider Report for Emergent BioSolutions Inc. (EBS)

Role
Director
Signature
/s/ S. Scott Lieberman, Attorney-in-fact
Stock symbol
EBS
Transactions as of
Apr 1, 2022
Transactions value $
$0
Form type
3
Date filed
4/5/2022, 04:18 PM
Previous filing
Feb 3, 2022
Next filing
Apr 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding EBS Common Stock 0 Apr 1, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Exhibit list: Ex 24.1 - Power of Attorney